logo

Our mission is to ensure the generation of accurate and precise findings.

GET UPDATE

Please enter subscribe form shortcode

InnoTech Precision Medicine Awarded NIH SBIR Phase II to Advance Point-of-Care Detection of HPV-Related Oropharyngeal Cancer

InnoTech Precision Medicine is proud to announce the receipt of Phase II funding from the NIH to continue the development of Recognize™-OPSCC, a saliva-based, point-of-care diagnostic test for oropharyngeal squamous cell carcinoma (OPSCC). OPSCC is the sixth most common cancer globally, with incidence rising due to high-risk HPV infections, particularly HPV16. Current screening methods rely […]